However, further studies show no change in the transplant outcome with the presence of SNPs in the NOD2/CARD15 gene in AML patients, and it affects only ALL patients, but the summary of these studies is shown in Table 4. The gene discussed is NOD2; the disease is acute myeloid leukemia.